| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.97 | 0.001 | 0.97 | Androgen antagonist | 0.928 0.002 CID_16654965 | ||
| 0.918 | 0.001 | 0.918 | Progesterone antagonist | 0.879 0.001 CID_16654965 | ||
| 0.915 | 0.001 | 0.949 | Glucocorticoid antagonist | 0.949 0.001 CID_16654965 | CID_16654965 | |
| 0.893 | 0.001 | 0.893 | Androgen agonist | 0.864 0.001 CID_16654965 | ||
| 0.845 | 0.001 | 0.886 | Lipocortins synthesis antagonist | 0.886 0.001 CID_16654965 | CID_16654965 | |
| 0.794 | 0.002 | 0.804 | Estrogen receptor alpha antagonist | 0.804 0.002 CID_16654965 | CID_16654965 | |
| 0.754 | 0.016 | 0.801 | Transcription factor NF kappa B inhibitor | 0.801 0.013 CID_16654965 | CID_16654965 | |
| 0.727 | 0.026 | 0.727 | Antiinflammatory | 0.717 0.028 CID_16654965 | ||
| 0.618 | 0.007 | 0.686 | Hypoxia-inducible factor 1 alpha inhibitor | 0.686 0.005 CID_16654965 | CID_16654965 | |
| 0.566 | 0.002 | 0.574 | Sodium/bile acid cotransporter inhibitor | 0.574 0.002 CID_16654965 | CID_16654965 | |
| 0.511 | 0.004 | 0.555 | Estrogen antagonist | 0.555 0.004 CID_16654965 | CID_16654965 | |
| 0.485 | 0.004 | 0.538 | Estrogen agonist | 0.538 0.003 CID_16654965 | CID_16654965 | |
| 0.453 | 0.005 | 0.461 | Antipruritic | 0.461 0.005 CID_16654965 | CID_16654965 | |
| 0.413 | 0.004 | 0.454 | Estrogen receptor beta antagonist | 0.454 0.004 CID_16654965 | CID_16654965 | |
| 0.48 | 0.08 | 0.517 | Apoptosis agonist | 0.517 0.069 CID_16654965 | CID_16654965 | |
| 0.39 | 0.01 | 0.39 | Lipid peroxidase inhibitor | 0.387 0.01 CID_16654965 | ||
| 0.431 | 0.053 | 0.453 | Immunosuppressant | 0.453 0.046 CID_16654965 | CID_16654965 | |
| 0.377 | 0.003 | 0.421 | Mineralocorticoid receptor antagonist | 0.421 0.003 CID_16654965 | CID_16654965 | |
| 0.401 | 0.047 | 0.563 | Aldehyde oxidase inhibitor | 0.563 0.024 CID_16654965 | CID_16654965 | |
| 0.323 | 0.002 | 0.355 | Progesterone agonist | 0.355 0.001 CID_16654965 | CID_16654965 | |
| 0.395 | 0.076 | 0.416 | 15-Lipoxygenase inhibitor | 0.416 0.068 CID_16654965 | CID_16654965 | |
| 0.292 | 0.004 | 0.342 | Estrogen receptor alpha agonist | 0.342 0.003 CID_16654965 | CID_16654965 | |
| 0.307 | 0.031 | 0.382 | Anesthetic general | 0.382 0.019 CID_16654965 | CID_16654965 | |
| 0.269 | 0.003 | 0.287 | Arachidonic acid antagonist | 0.287 0.002 CID_16654965 | CID_16654965 | |
| 0.283 | 0.02 | 0.283 | NOS3 expression enhancer | 0.249 0.027 CID_16654965 | ||
| 0.274 | 0.035 | 0.303 | P-glycoprotein inhibitor | 0.303 0.028 CID_16654965 | CID_16654965 | |
| 0.342 | 0.128 | 0.396 | Cyclophilin D inhibitor | 0.396 0.093 CID_16654965 | CID_16654965 | |
| 0.215 | 0.004 | 0.238 | 5-Alpha-reductase inhibitor | 0.238 0.004 CID_16654965 | CID_16654965 | |
| 0.207 | 0.004 | 0.23 | Anabolic | 0.23 0.002 CID_16654965 | CID_16654965 | |
| 0.236 | 0.056 | 0.248 | Nitric oxide antagonist | 0.248 0.052 CID_16654965 | CID_16654965 | |
| 0.182 | 0.005 | 0.205 | Estrogen receptor beta agonist | 0.205 0.005 CID_16654965 | CID_16654965 | |
| 0.185 | 0.009 | 0.509 | Aromatase inhibitor | 0.509 0.003 CID_16654965 | CID_16654965 | |
| 0.227 | 0.061 | 0.227 | MAP kinase kinase 3 inhibitor | |||
| 0.283 | 0.129 | 0.283 | Antiobesity | 0.254 0.153 CID_16654965 | ||
| 0.14 | 0.004 | 0.148 | Estrone sulfatase inhibitor | 0.148 0.004 CID_16654965 | CID_16654965 | |
| 0.201 | 0.076 | 0.254 | Neurotrophic factor enhancer | 0.254 0.036 CID_16654965 | CID_16654965 | |
| 0.123 | 0.003 | 0.127 | Lipocortins synthesis agonist | 0.127 0.003 CID_16654965 | CID_16654965 | |
| 0.118 | 0.001 | 0.143 | Progesterone receptor A antagonist | 0.143 0.001 CID_16654965 | CID_16654965 | |
| 0.122 | 0.007 | 0.148 | Aldosterone antagonist | 0.148 0.005 CID_16654965 | CID_16654965 | |
| 0.117 | 0.005 | 0.133 | RNA-directed RNA polymerase stimulant | 0.133 0.004 CID_16654965 | CID_16654965 | |
| 0.116 | 0.009 | 0.172 | Estradiol 17 beta-dehydrogenase inhibitor | 0.172 0.005 CID_16654965 | CID_16654965 | |
| 0.109 | 0.003 | 0.122 | Glucocorticoid agonist | 0.122 0.003 CID_16654965 | CID_16654965 | |
| 0.153 | 0.048 | 0.153 | Pregnane X receptor agonist | |||
| 0.155 | 0.055 | 0.155 | Bone formation stimulant | 0.144 0.064 CID_16654965 | ||
| 0.097 | 0.002 | 0.102 | Progesterone receptor B antagonist | 0.102 0.002 CID_16654965 | CID_16654965 | |
| 0.163 | 0.072 | 0.192 | Interleukin 6 antagonist | 0.192 0.046 CID_16654965 | CID_16654965 | |
| 0.157 | 0.072 | 0.215 | Diuretic | 0.215 0.039 CID_16654965 | CID_16654965 | |
| 0.095 | 0.02 | 0.095 | Adrenaline uptake inhibitor | 0.083 0.025 CID_16654965 | ||
| 0.149 | 0.079 | 0.188 | Interferon gamma antagonist | 0.188 0.046 CID_16654965 | CID_16654965 | |
| 0.074 | 0.022 | 0.092 | Alpha tubulin antagonist | 0.092 0.016 CID_16654965 | CID_16654965 | |
| 0.054 | 0.003 | 0.061 | Corticosteroid-like | 0.061 0.003 CID_16654965 | CID_16654965 | |
| 0.097 | 0.049 | 0.132 | Antineoplastic alkaloid | 0.132 0.033 CID_16654965 | CID_16654965 | |
| 0.206 | 0.16 | 0.224 | Caspase 3 stimulant | 0.224 0.138 CID_16654965 | CID_16654965 | |
| 0.075 | 0.032 | 0.087 | Beta tubulin antagonist | 0.087 0.027 CID_16654965 | CID_16654965 | |
| 0.148 | 0.112 | 0.165 | Hepatoprotectant | 0.165 0.094 CID_16654965 | CID_16654965 | |
| 0.117 | 0.083 | 0.135 | Tubulin antagonist | 0.135 0.067 CID_16654965 | CID_16654965 | |
| 0.066 | 0.032 | 0.067 | Heme oxygenase stimulant | 0.067 0.031 CID_16654965 | CID_16654965 | |
| 0.044 | 0.017 | 0.046 | Glucose-6-phosphate dehydrogenase inhibitor | 0.046 0.014 CID_16654965 | CID_16654965 | |
| 0.031 | 0.009 | 0.038 | 5-Alpha-reductase 1 inhibitor | 0.038 0.008 CID_16654965 | CID_16654965 | |
| 0.188 | 0.167 | 0.188 | Gastrin inhibitor | |||
| 0.121 | 0.101 | 0.13 | Farnesoid X receptor antagonist | 0.13 0.082 CID_16654965 | CID_16654965 | |
| 0.055 | 0.035 | 0.056 | Acetylcholine M2 receptor agonist | 0.056 0.034 CID_16654965 | CID_16654965 | |
| 0.027 | 0.01 | 0.107 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.107 0.004 CID_16654965 | CID_16654965 | |
| 0.073 | 0.057 | 0.088 | Na+ K+ transporting ATPase inhibitor | 0.088 0.043 CID_16654965 | CID_16654965 | |
| 0.025 | 0.01 | 0.032 | 5-Alpha-reductase 2 inhibitor | 0.032 0.009 CID_16654965 | CID_16654965 | |
| 0.015 | 0.005 | 0.015 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.015 0.005 CID_16654965 | ||
| 0.074 | 0.069 | 0.074 | Opioid kappa receptor antagonist | 0.074 0.068 CID_16654965 | ||
| 0.044 | 0.039 | 0.044 | Dopamine transporter inhibitor | |||
| 0.015 | 0.012 | 0.016 | Thyroid hormone alpha antagonist | 0.016 0.011 CID_16654965 | CID_16654965 | |
| 0.054 | 0.052 | 0.054 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.028 | 0.027 | 0.051 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.051 0.011 CID_16654965 | CID_16654965 | |
| 0.005 | 0.005 | 0.007 | Transcortin receptor antagonist | 0.007 0.003 CID_16654965 | CID_16654965 | |
| 0.251 | 0.252 | 0.256 | Caspase 9 stimulant | 0.256 0.246 CID_16654965 | CID_16654965 | |
| 0.153 | 0.162 | 0.164 | Antioxidant | 0.164 0.148 CID_16654965 | CID_16654965 | |
| 0.192 | 0.204 | 0.282 | Interleukin 2 agonist | 0.282 0.087 CID_16654965 | CID_16654965 | |
| 0.176 | 0.189 | 0.197 | Cholesterol antagonist | 0.197 0.167 CID_16654965 | CID_16654965 | |
| 0.086 | 0.119 | 0.098 | Microtubule formation inhibitor | 0.098 0.095 CID_16654965 | CID_16654965 | |
| 0.036 | 0.079 | 0.048 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.048 0.047 CID_16654965 | CID_16654965 | |
| 0.025 | 0.127 | 0.047 | GABA A receptor antagonist | 0.047 0.045 CID_16654965 | CID_16654965 | |
| 0.024 | 0.13 | 0.048 | GABA receptor antagonist | 0.048 0.047 CID_16654965 | CID_16654965 | |
| 0.109 | 0.292 | 0.156 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.156 0.136 CID_16654965 | CID_16654965 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |